More Healthcare Articles

Healthcare

OIG Issues 2013 Guidance On Provider Self-Disclosure Protocol

Charged with protecting the integrity of federal healthcare funds, the U.S. Department of Health and Human Services’ Office of the Inspector General (OIG) has allowed parties in violation of the law to self-report their actions under its self-disclosure protocol (SDP) as a method of...

Read More

Healthcare | Life Sciences

A Landmark Case Comes Down

Editor: Please describe your background as a life science patent attorney at Phillips Lytle. Clower: I hold a PhD in molecular biology from the University at Buffalo School of Medicine and Biomedical Sciences, where my research focused on elucidating the bimolecular mechanisms of mammalian DNA...

Read More

Healthcare | Life Sciences

Buyer Beware: Important “Supply” Issues For Life Science Companies

Very often, a biotech or other life sciences company will need to purchase materials or products from a third party vendor. This arrangement could be in connection with the company’s clinical testing/R&D or in connection with the company’s commercial supply of its product. In any...

Read More